Leerink Partnrs Boosts Earnings Estimates for CVS Health

CVS Health Corporation (NYSE:CVS - Free Report) - Leerink Partnrs lifted their FY2025 earnings per share estimates for shares of CVS Health in a research report issued to clients and investors on Thursday, July 10th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will post earnings of $6.18 per share for the year, up from their prior estimate of $6.16. The consensus estimate for CVS Health's current full-year earnings is $5.89 per share.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter in the previous year, the business earned $1.31 EPS. The company's quarterly revenue was up 7.0% compared to the same quarter last year.

CVS has been the topic of a number of other reports. Royal Bank Of Canada boosted their target price on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 target price (up from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Cowen reaffirmed a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Finally, UBS Group raised their price objective on shares of CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research note on Friday, May 2nd. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, CVS Health presently has a consensus rating of "Moderate Buy" and an average target price of $75.06.

CVS Health Price Performance

NYSE:CVS traded down $0.89 during trading hours on Friday, reaching $64.73. 7,020,831 shares of the company's stock were exchanged, compared to its average volume of 10,796,063. The company has a market capitalization of $81.88 billion, a P/E ratio of 15.45, a price-to-earnings-growth ratio of 0.94 and a beta of 0.57. CVS Health has a 12 month low of $43.56 and a 12 month high of $72.51. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. The business's 50-day simple moving average is $65.05 and its two-hundred day simple moving average is $62.22.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.11%. The ex-dividend date is Tuesday, July 22nd. CVS Health's payout ratio is currently 63.48%.

Insiders Place Their Bets

In other news, Director Guy P. Sansone bought 1,570 shares of the company's stock in a transaction on Thursday, June 5th. The shares were bought at an average cost of $63.70 per share, with a total value of $100,009.00. Following the transaction, the director directly owned 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.22% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of CVS. Bell Investment Advisors Inc increased its holdings in shares of CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock valued at $31,000 after acquiring an additional 248 shares during the last quarter. Roxbury Financial LLC increased its holdings in shares of CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator's stock valued at $32,000 after acquiring an additional 202 shares during the last quarter. Saudi Central Bank acquired a new position in shares of CVS Health during the 1st quarter valued at about $34,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the 2nd quarter valued at about $35,000. Finally, Costello Asset Management INC increased its holdings in shares of CVS Health by 281.3% during the 1st quarter. Costello Asset Management INC now owns 572 shares of the pharmacy operator's stock valued at $39,000 after acquiring an additional 422 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.